Two reviewers independently assessed and selected studies for inclusion and subsequently resolved discrepancies by discussion
Manufacturer prescribing information NovoCare (Ozempic, Wegovy, Rybelsus, Saxenda) and Lilly (Mounjaro, Zepbound)
Excluding patients who already had ESRD, the results showed that LN patients not on GLP-1Ras were twice as likely to progress to ESRD or dialysis dependence within five years compared to those using GLP-1Ras (OR 2.35, 95% CI 1.39, 3.976)
This histone modification has been shown to upregulate key pathways and proteins, including Wnt/-catenin, NF-B, PD-L1, and GDF15, thereby contributing to immune escape and therapeutic resistance in brain tumors (Fig
Gadaleta, V
If the drugs can treat or prevent psychiatric problems, the impact could be huge, given that 20% of Americans live with a mental illness and many dont have an effective treatment